AC Immune (ACIU) EBITDA Margin Growth (1y) (2016 - 2026)
AC Immune (ACIU) EBITDA Margin Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,552.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,536.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -170.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1,049.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AC Immune | 225.68 Mn | 225.68 Mn | - | 63,503.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,503.00 |
| Dec 31, 2025 | -262,111.00 |
| Sep 30, 2025 | -175,014.00 |
| Jun 30, 2025 | 156,656.00 |
| Dec 31, 2020 | 12,675.00 |
| Sep 30, 2020 | -249,167.00 |
| Jun 30, 2020 | -47,071.00 |
| Mar 31, 2020 | -13,962.00 |
| Dec 31, 2019 | -89,630.00 |
| Sep 30, 2019 | 134,516.00 |
| Jun 30, 2019 | -40,725.00 |
| Mar 31, 2019 | 85,671.00 |
| Dec 31, 2018 | -137,930.00 |
| Sep 30, 2018 | 115,077.00 |
| Jun 30, 2018 | 76,674.00 |
| Mar 31, 2018 | -30,379.00 |
| Dec 31, 2017 | -82,857.00 |
| Sep 30, 2017 | -105,757.00 |
| Mar 31, 2017 | 71,493.00 |
| Dec 31, 2016 | 89,891.00 |